River Road Asset Management, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
River Road Asset Management, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2022$6,958,000
-77.2%
93,995
-79.9%
0.10%
-75.7%
Q2 2022$30,547,000
-48.7%
468,655
-50.3%
0.43%
-35.0%
Q1 2022$59,575,000
+41.2%
942,341
+18.4%
0.66%
+46.5%
Q4 2021$42,204,000
+46.2%
795,700
+94.6%
0.45%
+40.8%
Q3 2021$28,863,000
+48.0%
408,887
+39.7%
0.32%
+52.6%
Q2 2021$19,500,000292,6160.21%
Other shareholders
HAEMONETICS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders